Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting: A Midazolam-controlled Randomized Controlled Trial
This is a double-blind active placebo controlled clinical trial for individuals with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.
- Status
- recruiting
- Phase
- Phase 3
- Institution
- Theresa Jacob, PhD, MPH
- Principal investigator
- Theresa Jacob, PhD, MPH
- Start date
- 2024-10-16
- End date
- 2027-09-30
- Registry ID
- NCT06752759
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.